+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Pneumoconiosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Pneumoconiosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Pulmonary Sarcoidosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Sarcoidosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Malignant Pleural Effusion - Epidemiology Forecast to 2032 - Product Thumbnail Image

Malignant Pleural Effusion - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cystic fibrosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cystic fibrosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Ofev (Nintedanib) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Ofev (Nintedanib) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
From
From
Cystic Fibrosis Therapeutics Market - Product Thumbnail Image

Cystic Fibrosis Therapeutics Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Montelukast Sodium Market - Product Thumbnail Image

Montelukast Sodium Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Epinephrine Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Epinephrine Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
VAC 18193 Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

VAC 18193 Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
OZAWADE Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

OZAWADE Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
From
From
From
From
From
From
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more